ValueScreener

ValueScreener company report

IBEX Limited (IBEX)

NASDAQ / Technology / Information Technology Services

Share price

45.91 USD Market dataClose of Oct 15, 2026

Market capitalisation

609.6M USD Market dataClose of Oct 15, 2026
Market data
Oct 15, 2026
Filed accounts
FY2026, filed Sep 10, 2026
Ratios computed
Oct 15, 2026
Filed years
6, FY2021 to FY2026
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on invested capital, after tax

23.2% Computed

From the FY2026 filing

Read quality

Valuation

Price to earnings

13.31x Computed

FY2026 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

4.6% Computed

FY2026 accounts, priced at the latest close

Read cash generation

Revenue and net income, by fiscal year

FY2016 Revenue: 323.0M USDFY2016 Net income: 1.6M USDFY2019 Revenue: 368.4M USDFY2019 Net income: -4.5M USDFY2020 Revenue: 405.1M USDFY2020 Net income: 7.8M USDFY2021 Revenue: 443.4M USDFY2021 Net income: 13.1M USDFY2022 Revenue: 492.9M USDFY2022 Net income: 21.5M USDFY2023 Revenue: 523.1M USDFY2023 Net income: 31.6M USDFY2024 Revenue: 508.6M USDFY2024 Net income: 33.7M USDFY2025 Revenue: 558.3M USDFY2025 Net income: 36.9M USDFY2026 Revenue: 644.1M USDFY2026 Net income: 46.3M USD
Revenue Net income9 fiscal years; a year whose statement names no SEC filing is market data, and the table in Filings says which.
Named tests met
6 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 13.31x at the close of 2026-10-15 on FY2026 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 10.00x and 15.00x.

Today, against the Information Technology Services industry (41 companies), 13.31x sits at the 25th percentile; the middle half of that group runs from 13.31x to 25.20x.

Is it good

Return on invested capital was 23.2% in FY2026, in the band labelled "Exceptional" (20.0% and above), on lines anchored on Damodaran's cost-of-capital data, suggesting returns on the capital in the business well above the usual cost of that capital.

Today, against the Technology sector (220 companies), 23.2% sits at the 80th percentile; the middle half of that group runs from 1.2% to 17.5%.

Is it safe

Interest coverage was 58.72x in FY2026, in the band labelled "Comfortable" (6.00x and above), on lines anchored on Damodaran's interest-coverage table, suggesting an interest bill operating profit covers many times over.

Year by year against peers
Whether IBEX Limited's return on invested capital stayed above the median of the Technology sector, year by year. (FY2023 to FY2025, 3 fiscal years of IBEX Limited with a comparable figure)
The direction
Which way IBEX Limited's operating margin has moved, and how steadily. (FY2016 to FY2026, 9 filed years of IBEX Limited)
What could explain it
What in IBEX Limited's filed statements could explain the movements. (10 readings drawn from the statement lines IBEX Limited filed)
What to check next
What to check next on IBEX Limited, and where in its filings. (3 questions for IBEX Limited)
In one paragraph
One paragraph on IBEX Limited's returns, cash, balance sheet and price. (14 of sixteen figures read for IBEX Limited)

These are IBEX’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research IBEXPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2026 annual report: 10-K, filed Sep 10, 2026, accession 0001720420-26-000025.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

IBEX Limited: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax23.2% ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Return on equity27.2% ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Return on capital employed, pre-tax24.6% ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Return on assets15.0% ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Gross margin
Why n/a

Our archived statements for this filer carry no gross profit line, so there is nothing to compute a gross margin from and trace back to source. That may be because the filer presents no cost of revenue, or because we have not captured the concept. We do not guess which.

n/a ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Operating margin8.5% ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Net margin7.2% ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
IBEX 7.2%
TASK 8.6%VRRM 14.0%GDYN 2.4%NYAX 8.9%NABL -3.7%
-3.7%14.0%
Net margin: IBEX against the 5 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

IBEX Limited: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity0.38 ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Current ratio2.10 ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Quick ratio2.10 ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Interest coverage58.72x ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Altman Z-score6.30 ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Net debt31.5M ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Total assets 309.1MTotal liabilities 138.9MShareholders' equity 170.2MOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What IBEX Limited owned and owed at the end of fiscal 2026, from the balance sheet it filed (10-K, filed Sep 10, 2026, 0001720420-26-000025).

IBEX Limited: balance sheet position
Total assets309.1M FiledFY2026 10-K, filed Sep 10, 2026
Total liabilities138.9M FiledFY2026 10-K, filed Sep 10, 2026
Shareholders' equity170.2M FiledFY2026 10-K, filed Sep 10, 2026
Cash32.6M FiledFY2026 10-K, filed Sep 10, 2026
Total debt64.1M FiledFY2026 10-K, filed Sep 10, 2026
Net debt31.5M
Current ratio2.10
Debt to equity0.38

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

IBEX Limited: what the market charges, each with its source
FigureValue, source and document
Price to earnings13.31x ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
P/E on trailing twelve months14.30x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book3.99x ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Price to sales1.06x ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Enterprise value to EBIT12.94x ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Enterprise value to EBITDA9.50x ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Price to earnings over growth0.37 ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Diluted earnings per share3.13 USD FiledFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Graham number29.87 USD ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025

We publish no fair value or price target of our own. Value IBEX on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for IBEX Limited today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

IBEX Limited: valuation
Share price45.91 USD
Market capitalisation609.6M USD
Enterprise value to EBITDA9.50x
Graham number29.87 USD
Diluted earnings per share, FY20263.13 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Nov 9, 2023: low 6.97x, median 10.98x, high 17.80x, latest 14.30x. 734 trading days with a meaningful ratio. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like IBEX Limited

  1. TaskUs, Inc. (TASK)Market cap 781.2M USD
  2. Verra Mobility Corporation (VRRM)Market cap 446.8M USD
  3. Grid Dynamics Holdings, Inc. (GDYN)Market cap 649.8M USD
  4. Nayax Ltd. (NYAX)Market cap 1.67B USD
  5. N-able, Inc. (NABL)Market cap 869.0M USD

Same industry (Information Technology Services) and size band (Small, 300M to 2B), nearest in market value, net margin and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

IBEX Limited: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield4.6% ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Free cash flow31.2M USD ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Free cash flow margin4.8% ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Dividend yield
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Payout ratio
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
FY2016 Free cash flow: -7.8M USDFY2016 Net income: 1.6M USDFY2019 Free cash flow: -4.0M USDFY2019 Net income: -4.5M USDFY2020 Free cash flow: 47.4M USDFY2020 Net income: 7.8M USDFY2021 Free cash flow: -4.7M USDFY2021 Net income: 13.1M USDFY2022 Free cash flow: 14.1M USDFY2022 Net income: 21.5M USDFY2023 Free cash flow: 22.9M USDFY2023 Net income: 31.6M USDFY2024 Free cash flow: 27.0M USDFY2024 Net income: 33.7M USDFY2025 Free cash flow: 27.3M USDFY2025 Net income: 36.9M USDFY2026 Free cash flow: 31.2M USDFY2026 Net income: 46.3M USD
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

IBEX Limited: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
13.31xFY2026Oct 15, 2026
3.99xFY2026Oct 15, 2026
12.94xFY2026Oct 15, 2026
4.6%FY2026Oct 15, 2026
23.2%FY2026Sep 10, 2026
n/aFY2026Oct 15, 2026
n/a The filed cash flow statement reports no dividend paid at all. That is not the same as a filed zero, and we will not read it as one.
0.38FY2026Sep 10, 2026
2.10FY2026Sep 10, 2026
1.06xFY2026Oct 15, 2026
0.37FY2026Oct 15, 2026
6.30FY2026Oct 15, 2026
-2.57FY2026Sep 10, 2026
8/9FY2026Sep 10, 2026

The figures are computed from the accounts for fiscal 2026, the newest full year on file. 6 filed fiscal years on record, FY2021 to FY2026, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

9 fiscal years, FY2016 to FY2026. 6 read from the annual reports IBEX Limited filed with the SEC, each naming its filing; the rest from statements that name none, which are market data. Amounts in USD, as reported.

IBEX Limited: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY2026644.1M55.0M46.3M3.1331.2M8.5%27.2%10-K, Sep 10, 20260001720420-26-000025
FY2025558.3M46.6M36.9M2.3627.3M8.3%27.4%10-K, Sep 11, 20250001720420-25-000027
FY2024508.6M39.4M33.7M1.8427.0M7.8%20.3%10-K, Sep 12, 20240001720420-24-000042
FY2023523.1M40.5M31.6M1.6722.9M7.7%21.1%10-K, Sep 13, 20230001720420-23-000013
FY2022492.9M20.6M21.5M1.1514.1M4.2%18.9%10-K, Sep 13, 20230001720420-23-000013
FY2021443.4M17.0M13.1M0.71-4.7M3.8%n/a10-K, Sep 13, 20230001720420-23-000013
FY2020405.1M19.5M7.8M0.4447.4M4.8%48.1%Market data, supplied Oct 15, 2026accession n/a
FY2019368.4M6.8M-4.5M-0.26-4.0M1.9%-52.4%Market data, supplied Oct 15, 2026accession n/a
FY2016323.0M8.6M1.6M0.09-7.8M2.6%9.8%Market data, supplied Oct 15, 2026accession n/a
  • Revenue, compound annual growth FY2016 to FY2026: 7.1%
  • Earnings, compound annual growth FY2016 to FY2026: 40.3%
  • Earnings per share, compound annual growth FY2016 to FY2026: 42.8%
  • Free cash flow: Free cash flow was not positive in both 2016 and 2026, so a compound rate across the window is not defined. Both figures are in the table.

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

IBEX Limited: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score-2.57 ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Piotroski F-score8/9 ComputedFY2026 10-K, filed Sep 10, 2026, 0001720420-26-000025
Named tests met6 of 30 Computed
Beta1.00 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 6 met, 20 not met, 4 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
Three forensic scores; High returns and growth; ROIC at or above WACC; Z-score and coverage (Edward Altman); Low P/S, rising earnings (James O'Shaughnessy); Clean books, high ROIC
Does not
Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; Earnings yield and ROIC (Joel Greenblatt); High F-score, low P/B (Joseph Piotroski); Low PEG, low debt (Peter Lynch); EV/EBITDA and coverage; Low beta, profitable; Near the 52-week low; Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; Owner earnings yield; High return on tangibles; Book or below, low debt (Walter Schloss); Tangible book or below; Cash-flow yield and ROIC; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured
Gross margin, turnover (Robert Novy-Marx); High yield, low payout; Dividends and buybacks; Cash-covered dividend. A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(5)
  • Gross Margin: Our archived statements for this filer carry no gross profit line, so there is nothing to compute a gross margin from and trace back to source. That may be because the filer presents no cost of revenue, or because we have not captured the concept. We do not guess which.
  • Dividend Yield: We do not hold this figure for this company, so there is nothing to show.
  • Payout Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Coverage Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Streak: We do not hold this figure for this company, so there is nothing to show.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 5 figures could not be read on this company, among them Gross Margin, Dividend Yield, Payout Ratio. Each blank in the table above names the rest, with its reason. 4 named tests come back incomplete because of them, which is neither met nor missed.
  • We hold 6 filed fiscal years rather than 10, so the run above is shorter than a full decade and is counted as what it is.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map
  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.